标题
The immunomodulatory effects of endocrine therapy in breast cancer
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-07
DOI
10.1186/s13046-020-01788-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial
- (2020) Robert H Jones et al. LANCET ONCOLOGY
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment
- (2020) Wei Zhang et al. Frontiers in Immunology
- Fulvestrant-Mediated Attenuation of the Innate Immune Response Decreases ER+ Breast Cancer Growth In Vivo More Effectively than Tamoxifen
- (2020) Annelie Abrahamsson et al. CANCER RESEARCH
- Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype
- (2019) Lena Lau et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy
- (2019) Adrienne G Waks et al. CLINICAL CANCER RESEARCH
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
- (2019) Seock-Ah Im et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
- (2019) George W. Sledge et al. JAMA Oncology
- The PI3K/AKT/mTOR and CDK4/6 Pathways in Endocrine Resistant HR+/HER2− Metastatic Breast Cancer: Biological Mechanisms and New Treatments
- (2019) Daniele Presti et al. Cancers
- The Immune Microenvironment of Breast Cancer Progression
- (2019) Tower et al. Cancers
- Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
- (2019) Diana C. Márquez-Garbán et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation
- (2019) Di Guo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells
- (2018) Yuting Deng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase II Study of Taselisib (GDC‑0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer
- (2018) Maura N. Dickler et al. CLINICAL CANCER RESEARCH
- Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
- (2018) Hope S. Rugo et al. CLINICAL CANCER RESEARCH
- Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
- (2018) Sabino De Placido et al. LANCET ONCOLOGY
- Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
- (2018) Debu Tripathy et al. LANCET ONCOLOGY
- Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages
- (2018) Evangelia Goulielmaki et al. Cell Death & Disease
- The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
- (2018) David A. Schaer et al. Cell Reports
- Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer
- (2018) Angélica Aponte-López et al. Journal of Immunology Research
- T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response
- (2018) Laura Aragoneses-Fenoll et al. Frontiers in Immunology
- A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice
- (2018) Jae-Hyeog Choi et al. OncoImmunology
- Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
- (2018) Zhe-Yu Hu et al. EBioMedicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Everolimus-based combination therapies for HR+, HER2− metastatic breast cancer
- (2018) Joyce O'Shaughnessy et al. CANCER TREATMENT REVIEWS
- Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)
- (2018) Xu Liang et al. Journal of Hematology & Oncology
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer
- (2018) Dejan Juric et al. JAMA Oncology
- Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) José Baselga et al. LANCET ONCOLOGY
- CDK4/6 inhibition triggers anti-tumour immunity
- (2017) Shom Goel et al. NATURE
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
- (2017) Luca Magnani et al. NATURE GENETICS
- Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
- (2017) Kazuhiro Araki et al. Breast Cancer
- CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
- (2017) Jiehui Deng et al. Cancer Discovery
- Immunotherapeutic target expression on breast tumors can be amplified by hormone receptor antagonism: a novel strategy for enhancing efficacy of targeted immunotherapy
- (2017) Ritika Jaini et al. Oncotarget
- The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation
- (2017) Honyin Chiu et al. Frontiers in Immunology
- Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution
- (2017) Hwa Hwa Chung et al. Scientific Reports
- Gonadotropin-releasing hormone analogues lead to pro-inflammatory changes in T lymphocytes
- (2016) Nayoung Sung et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells
- (2016) John O. Richards et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER + Breast Cancer
- (2016) Sarah R. Hosford et al. CLINICAL CANCER RESEARCH
- PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses
- (2016) Jiqing Sai et al. CLINICAL CANCER RESEARCH
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- ERβ in CD4+T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity
- (2016) Maria Aggelakopoulou et al. JOURNAL OF IMMUNOLOGY
- mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α
- (2016) Guangchao Cao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Antiestrogens: structure activity relationships and use in breast cancer treatment
- (2016) Tatiana Traboulsi et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Ian E Krop et al. LANCET ONCOLOGY
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells
- (2016) Daniel M. Houslay et al. Science Signaling
- Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
- (2016) Nikolaos Svoronos et al. Cancer Discovery
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells
- (2016) Daniel M. Houslay et al. Science Signaling
- The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation
- (2016) Roxana Flores et al. Frontiers in Immunology
- mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
- (2016) Tingting Wu et al. Scientific Reports
- Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication
- (2015) N. Chaoul et al. CANCER RESEARCH
- Estrogen receptors regulate innate immune cells and signaling pathways
- (2015) Susan Kovats CELLULAR IMMUNOLOGY
- CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
- (2015) S. Svensson et al. CLINICAL CANCER RESEARCH
- The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
- (2015) Gustavo J. Martinez et al. IMMUNITY
- Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms
- (2015) Belén Blanco et al. IMMUNOLOGIC RESEARCH
- Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function
- (2015) Belén Blanco et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
- (2015) Kristen N. Pollizzi et al. JOURNAL OF CLINICAL INVESTIGATION
- Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer
- (2015) Xuyi Wang et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
- (2015) Jack Cuzick et al. LANCET ONCOLOGY
- Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants
- (2015) Veronica De Rosa et al. NATURE IMMUNOLOGY
- Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide
- (2015) Ross Corriden et al. Nature Communications
- A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
- (2015) Maria Gato-Cañas et al. Oncotarget
- Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals
- (2015) Qun Rao et al. Oncotarget
- Milestones in Breast Cancer Treatment
- (2014) Stefano Zurrida et al. Breast Journal
- Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance
- (2014) Sarah A. Dabydeen et al. CARCINOGENESIS
- Effect of Aromatase Inhibition on Functional Gene Modules in Estrogen Receptor-Positive Breast Cancer and Their Relationship with Antiproliferative Response
- (2014) Q. Gao et al. CLINICAL CANCER RESEARCH
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
- (2014) Antoine Marçais et al. NATURE IMMUNOLOGY
- Identification of a Role for the PI3K/AKT/mTOR Signaling Pathway in Innate Immune Cells
- (2014) Songbo Xie et al. PLoS One
- Selective Inhibition of Regulatory T Cells by Targeting the PI3K-Akt Pathway
- (2014) R. Abu-Eid et al. Cancer Immunology Research
- The Critical Role of IL-15–PI3K–mTOR Pathway in Natural Killer Cell Effector Functions
- (2014) Neethi Nandagopal et al. Frontiers in Immunology
- Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
- (2013) J. Thaddeus Beck et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Profiling of Aromatase Inhibitor-Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
- (2013) A. K. Dunbier et al. CLINICAL CANCER RESEARCH
- Rapamycin unbalances the polarization of human macrophages to M1
- (2013) Alessia Mercalli et al. IMMUNOLOGY
- Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients – an immunohistochemical study of cd8+ and foxp3+ using double immunostaining with correlation to the pathobiological response of the patients
- (2013) Monica SM Chan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Macrophage-Induced Tumor Angiogenesis Is Regulated by the TSC2-mTOR Pathway
- (2012) W. Chen et al. CANCER RESEARCH
- Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice
- (2012) E. Amiel et al. JOURNAL OF IMMUNOLOGY
- Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
- (2012) A. Arranz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- PI3K p110 regulates T-cell cytokine production during primary and secondary immune responses in mice and humans
- (2010) D. R. Soond et al. BLOOD
- Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer
- (2010) Maurizia Mello-Grand et al. BREAST CANCER RESEARCH AND TREATMENT
- Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro
- (2010) Haishan Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antiestrogens Induce Transforming Growth Factor -Mediated Immunosuppression in Breast Cancer
- (2010) C. M. Joffroy et al. CANCER RESEARCH
- An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness
- (2010) Claudio Procaccini et al. IMMUNITY
- A Versatile Role of Mammalian Target of Rapamycin in Human Dendritic Cell Function and Differentiation
- (2010) M. Haidinger et al. JOURNAL OF IMMUNOLOGY
- Enhancement of antigen-specific Treg vaccination in vivo
- (2010) C. Daniel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PIKing the right isoform: the emergent role of the p110β subunit in breast cancer
- (2010) Silvia Carvalho et al. VIRCHOWS ARCHIV
- Tamoxifen Induces Expression of Immune Response-Related Genes in Cultured Normal Human Mammary Epithelial Cells
- (2009) L. J. Schild-Hay et al. CANCER RESEARCH
- PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer
- (2009) R. J. Crowder et al. CANCER RESEARCH
- Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
- (2009) D. Generali et al. CLINICAL CANCER RESEARCH
- The Effects of Tamoxifen on Immunity
- (2009) S. Behjati et al. CURRENT MEDICINAL CHEMISTRY
- Akt2 is required for macrophage chemotaxis
- (2009) Baogang Zhang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis
- (2009) Wang Jingxuan et al. EXPERIMENTAL GERONTOLOGY
- Anergic T Cells Are Metabolically Anergic
- (2009) Y. Zheng et al. JOURNAL OF IMMUNOLOGY
- Regulation of phosphoinositide 3-kinase expression in health and disease
- (2009) Klaartje Kok et al. TRENDS IN BIOCHEMICAL SCIENCES
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells
- (2008) Jingna Wang et al. CELLULAR SIGNALLING
- Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis
- (2008) Bruce F. Bebo et al. GLIA
- PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
- (2008) C A Crane et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now